Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000113

Options or other derivatives

  • GENERAL COUNSEL/CORPORATE SECR acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR 2019-01-30 Grant or award · Stock Options +50,000 50,000 D
Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR 2019-01-30 Grant or award · Restricted Stock Units +25,000 25,000 D
Loading xslF345X03/form4-01312019_040128.xml…